SEARCH

SEARCH BY CITATION

  • 1
    Xia, M. Q., Tone, M., Packman, L., Hale, G. and Waldmann, H., Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone. Eur. J. Immunol. 1991. 21: 16771684.
  • 2
    Gilleece, M. H. and Dexter, T. M., Effect of Campath-1H antibody on human hematopoietic progenitors in vitro. Blood 1993. 82: 807812.
  • 3
    Coles, A. J., Wing, M. G., Molyneux, P., Paolillo, A., Davie, C. M., Hale, G., Miller, D. et al., Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann. Neurol. 1999. 46: 296304.
  • 4
    Coles, A. J., Cox, A. L., Le Page, E., Jones, J. L., Trip, S. A., Deans, J. and Seaman, S. et al. The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J. Neurol. 2005, in press.
  • 5
    Hale, G., Rebello, P., Brettman, L. R., Fegan, C., Kennedy, B., Kimby, E., Leach, M. et al., Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration. Blood 2004. 104: 948955.
  • 6
    Carreras, E., Saiz, A., Marin, P., Martinez, C., Rovira, M., Villamor, N., Aymerich, M. et al., CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 2003. 88: 306314.
  • 7
    Wiles, C. M., Omar, L., Swan, A. V., Sawle, G., Frankel, J., Grunewald, R., Joannides, T. et al., Total lymphoid irradiation in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 1994. 57: 154163.
  • 8
    Issacs, J. D., Greer, S., Sharma, S., Symmons, D., Smith, M., Johnston, J., Waldmann, H. et al., Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia. Arthritis Rheum. 2001. 44: 19982008.
  • 9
    Ponchel, F., Verburg, R., Bingham, S., Brown, A., Moore, J., Protheroe, A., Short, K. et al., Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia. Arthritis Res. Ther. 2005. 7: R80R92.
  • 10
    Hakim, F. T., Memon, S. A., Cepeda, R., Jones, E. C., Chow, C. K., Kasten-Sportes, C., Odom, J. et al., Age-dependent incidence, time course, and consequences of thymic renewal in adults. J. Clin. Invest. 2005. 115: 930939.
  • 11
    Nachbaur, D., Kropshofer, G., Heitger, A., Latzer, K., Glassl, H., Ludescher, C., Nussbaumer, W. and Niederwieser, D., Phenotypic and functional lymphocyte recovery after CD34+-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation. J. Hematother. Stem Cell Res. 2000. 9: 727736.
  • 12
    Amigo, M. L., del Canizo, M. C., Caballero, M. D., Vazquez, L., Corral, M., Vidriales, B., Brufau, A. and San Miguel, J. F., Factors that influence long-term hematopoietic function following autologous stem cell transplantation. Bone Marrow Transplant. 1999. 24: 289293.
  • 13
    Dumont-Girard, F., Roux, E., van Lier, R. A., Hale, G., Helg, C., Chapuis, B., Starobinski, M. and Roosnek, E., Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 1998. 92: 44644471.
  • 14
    Thieblemont, C., Bouafia, F., Hornez, E., Dumontet, C., Tartas, S., Antal, D., Lemieux, B. et al., Maintenance therapy with a monthly injection of alemtuzumab prolongs response duration in patients with refractory B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL). Leuk. Lymphoma 2004. 45: 711714.
  • 15
    Lundin, J., Porwit-MacDonald, A., Rossmann, E. D., Karlsson, C., Edman, P., Rezvany, M. R., Kimby, E. et al., Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia. Leukemia 2004. 18: 484490.
  • 16
    Ploix, C., Lo, D. and Carson, M. J., A Ligand for the chemokine rReceptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity. J. Immunol. 2001. 167: 67246730.
  • 17
    Jameson, S. C., Maintaining the norm: T-cell homeostasis. Nat. Rev. Immunol. 2002. 2: 547556.
  • 18
    Marrack, P., Bender, J., Hildeman, D., Jordan, M., Mitchell, T., Murakami, M., Sakamoto, A. et al., Homeostasis of alpha beta TCR+ T cells. Nat. Immunol. 2000. 1: 107111.
  • 19
    Viret, C., Wong, F. S. and Janeway, C. A. Jr., Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity 1999. 10: 559568.
  • 20
    Dorfman, J. R., Stefanova, I., Yasutomo, K. and Germain, R. N., CD4+ T cell survival is not directly linked to self-MHC-induced TCR signaling. Nat. Immunol. 2000. 1: 329335.
  • 21
    Germain, R. N., Stefanova, I. and Dorfman, J., Self-recognition and the regulation of CD4+ T cell survival. Adv. Exp. Med. Biol. 2002. 512: 97105.
  • 22
    Chu, Y. W., Memon, S. A., Sharrow, S.O., Hakim, F. T., Eckhaus, M., Lucas, P. J. and Gress, R. E., Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood 2004. 104: 11101119.
  • 23
    Jiang, Q., Li, W. Q., Hofmeister, R. R., Young, H. A., Hodge, D. R., Keller, J. R., Khaled, A. R. and Durum, S. K., Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members. Mol. Cell Biol. 2004. 24: 65016513.
  • 24
    Fry, T. J. and Mackall, C. L., Interleukin-7: from bench to clinic. Blood 2002. 99: 38923904.
  • 25
    Fry, T. J. and Mackall, C. L., The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 2005. 174: 65716576.
  • 26
    Fry, T. J., Connick, E., Falloon, J., Lederman, M. M., Liewehr, D. J., Spritzler, J., Steinberg, S. M. et al., A potential role for interleukin-7 in T-cell homeostasis. Blood 2001. 97: 29832990.
  • 27
    Bolotin, E., Annett, G., Parkman, R. and Weinberg, K., Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant. 1999. 23: 783788.
  • 28
    Khan, I. A., Moretto, M., Wei, X.Q., Williams, M., Schwartzman, J. D. and Liew, F. Y., Treatment with sSoluble interleukin-15R{alpha} exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response. J. Exp. Med. 2002. 195: 14631470.
  • 29
    Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N. et al., Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 2000. 191: 771780.
  • 30
    Alpdogan, O., Eng, J. M., Muriglan, S. J., Willis, L. M., Hubbard, V. M., Tjoe, K. H., Terwey, T. H. et al., Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood 2005. 105: 865873.
  • 31
    Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J. and Marrack, P., Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 2000. 288: 675678.
  • 32
    Becker, T. C., Wherry, E. J., Boone, D., Murali-Krishna, K., Antia, R., Ma, A. and Ahmed, R., Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 2002. 195: 15411548.
  • 33
    Tan, J. T., Ernst, B., Kieper, W. C., LeRoy, E., Sprent, J. and Surh, C. D., Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 2002. 195: 15231532.
  • 34
    Baecher-Allan, C., Brown, J. A., Freeman, G. J. and Hafler, D. A., CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 2001. 167: 12451253.
  • 35
    Cozzo, C., Larkin, J., III and Caton, A. J., Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J. Immunol. 2003. 171: 56785682.
  • 36
    Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 10571061.
  • 37
    Ge, Q., Palliser, D., Eisen, H. N. and Chen, J., Homeostatic T cell proliferation in a T cell-dendritic cell coculture system. Proc. Natl. Acad. Sci. USA 2002. 99: 29832988.
  • 38
    Wagner, U., Pierer, M., Wahle, M., Moritz, F., Kaltenhauser, S. and Hantzschel, H., Ex vivo homeostatic proliferation of CD4+ T cells in rheumatoid arthritis is dysregulated and driven by membrane-anchored TNFalpha. J. Immunol. 2004. 173: 28252833.
  • 39
    Lyons, A. B., Hasbold, J. and Hodgkin, P. D., Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe. Methods Cell Biol. 2001. 63: 375398.
  • 40
    Givan, A. L., Fisher, J. L., Waugh, M., Ernstoff, M. S. and Wallace, P. K., A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J. Immunol. Methods 1999. 230: 99112.
  • 41
    Llewellyn-Smith, N., Lai, M., Miller, D. H., Rudge, P., Thompson, A. J. and Cuzner, M. L., Effects of anti-CD4 antibody treatment on lymphocyte subsets and stimulated tumor necrosis factor alpha production: a study of 29 multiple sclerosis patients entered into a clinical trial of cM-T412. Neurology 1997. 48: 810816.
  • 42
    Brett, S., Baxter, G., Cooper, H., Johnston, J. M., Tite, J. and Rapson, N., Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H. Immunology 1996. 88: 1319.
  • 43
    Wu, Z., Bensinger, S. J., Zhang, J., Chen, C., Yuan, X., Huang, X., Markmann, J. F. et al., Homeostatic proliferation is a barrier to transplantation tolerance. Nat. Med. 2004. 10: 8792.
  • 44
    Cho, B. K., Rao, V. P., Ge, Q., Eisen, H. N. and Chen, J., Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J. Exp. Med . 2000. 192: 549556.
  • 45
    Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y., Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003. 4: 330336.
  • 46
    Viglietta, V., Baecher-Allan, C., Weiner, H. L. and Hafler, D. A., Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J .Exp. Med. 2004. 199: 971979.
  • 47
    Goldrath, A. W., Bogatzki, L. Y. and Bevan, M. J., Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 2000. 192: 557564.
  • 48
    Hazenberg, M. D., Verschuren, M. C. M., Hamann, D., Miedema, F. and van Dongen, J. J. M., T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J. Mol. Med. 2001. 79: 631640.
  • 49
    Ye, P. and Kirschner, D. E., Measuring emigration of human thymocytes by T-cell receptor excision circles. Crit. Rev. Immunol. 2002. 22: 483497.
  • 50
    Coles, A. J., Wing, M., Smith, S., Coraddu, F., Greer, S., Taylor, C., Weetman, A. et al., Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 1999. 354: 16911695.
  • 51
    Kang, B. Y., Miaw, S. C. and Ho, I. C., ROG negatively regulates T-cell activation but is dispensable for Th-cell differentiation. Mol. Cell. Biol. 2005. 25: 554562.
  • 52
    Miaw, S. C., Kang, B. Y., White, I. A. and Ho, I. C., A Repressor of GATA-mediated negative feedback mechanism of T cell activation. J. Immunol. 2004. 172: 170177.
  • 53
    Miaw, S. C., Choi, A., Yu, E., Kishikawa, H. and Ho, I. C., ROG, repressor of GATA, regulates the expression of cytokine genes. Immunity 2000. 12: 323333.
  • 54
    Cobbold, S. P., Adams, E., Graca, L. and Waldmann, H., Serial analysis of gene expression provides new insights into regulatory T cells. Semin. Immunol. 2003. 15: 209214.
  • 55
    Park, J. H., Yu, Q., Erman, B., Appelbaum, J. S., Montoya-Durango, D., Grimes, H. L. and Singer, A., Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 2004. 21: 289302.
  • 56
    Kurtzke, J. F., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983. 33: 14441452.
  • 57
    Moreau, T., Coles, A., Wing, M., Isaacs, J., Hale, G., Waldmann, H. and Compston, A., Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 1996. 119 (Pt 1): 225237.
  • 58
    Wing, M. G., Waldmann, H., Isaacs, J., Compston, D. A. and Hale, G., Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotype. Ther. Immunol. 1995. 2: 183190.